167 / 172
167
patients with rheumatoid arthritis. Clin Exp Rheumatol
2011;29:238-47.
174.Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff
MH, Keystone EC, et al. A comparison of etanercept and
methotrexate in patients with early rheumatoid arthritis. N
Engl J Med 2000;343:1586-93.
175.Weinblatt ME, Schiff MH, Ruderman EM, Bingham CO
3rd, Li J, Louie J, et al. Efficacy and safety of etanercept 50 mg
twice a week in patients with rheumatoid arthritis who had a
suboptimal response to etanercept 50 mg once a week: results
of a multicenter, randomized, double-blind, active drug-
controlled study. Arthritis Rheum 2008;58:1921-30.
176.Westhovens R, Yocum D, Han J, Berman A, Strusberg I,
Geusens P, et al. The safety of infliximab, combined with
background treatments, among patients with rheumatoid
arthritis and various comorbidities: a large, randomized,
placebo-controlled trial. Arthritis Rheum 2006;54:1075-86.
177.St Clair EW, van der Heijde DM, Smolen JS, Maini RN,
Bathon JM, Emery P, et al. Combination of infliximab and
methotrexate therapy for early rheumatoid arthritis: a
randomized, controlled trial. Arthritis Rheum 2004;50: 3432-43.
178.Emery P, Fleischmann R, van der Heijde D, Keystone EC,
Genovese MC, Conaghan PG, et al. The effects of golimumab
on radiographic progression in rheumatoid arthritis: results of
randomized controlled studies of golimumab before
methotrexate therapy and golimumab after methotrexate
therapy. Arthritis Rheum 2011;63:1200-10.
179.Keystone EC, Genovese MC, Klareskog L, Hsia EC, Hall
ST, Miranda PC, et al. Golimumab, a human antibody to
tumour necrosis factor {alpha} given by monthly subcutaneous
injections, in active rheumatoid arthritis despite methotrexate
therapy: the GO-FORWARD Study. Ann Rheum Dis 2009;68:
789-96.